Global and Japan NSAIDs Market Insights, Forecast to 2026

Global and Japan NSAIDs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 NSAIDs Product Introduction
1.2 Market Segments
1.3 Key NSAIDs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global NSAIDs Market Size Growth Rate by Type
1.4.2 Aspirin
1.4.3 Ibuprofen
1.4.4 Naproxen
1.4.5 Nabumetone
1.4.6 Others
1.5 Market by Application
1.5.1 Global NSAIDs Market Size Growth Rate by Application
1.5.2 Back Pain Treatment
1.5.3 Osteoarthritis Treatment
1.5.4 Other Disease Treatment
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global NSAIDs Market Size, Estimates and Forecasts
2.1.1 Global NSAIDs Revenue 2015-2026
2.1.2 Global NSAIDs Sales 2015-2026
2.2 Global NSAIDs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 NSAIDs Historical Market Size by Region (2015-2020)
2.3.1 Global NSAIDs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global NSAIDs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 NSAIDs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global NSAIDs Sales Forecast by Region (2021-2026)
2.4.2 Global NSAIDs Revenue Forecast by Region (2021-2026)
3 Global NSAIDs Competitor Landscape by Players
3.1 Global Top NSAIDs Sales by Manufacturers
3.1.1 Global NSAIDs Sales by Manufacturers (2015-2020)
3.1.2 Global NSAIDs Sales Market Share by Manufacturers (2015-2020)
3.2 Global NSAIDs Manufacturers by Revenue
3.2.1 Global NSAIDs Revenue by Manufacturers (2015-2020)
3.2.2 Global NSAIDs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global NSAIDs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by NSAIDs Revenue in 2019
3.2.5 Global NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global NSAIDs Price by Manufacturers
3.4 Global NSAIDs Manufacturing Base Distribution, Product Types
3.4.1 NSAIDs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers NSAIDs Product Type
3.4.3 Date of International Manufacturers Enter into NSAIDs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global NSAIDs Market Size by Type (2015-2020)
4.1.1 Global NSAIDs Sales by Type (2015-2020)
4.1.2 Global NSAIDs Revenue by Type (2015-2020)
4.1.3 NSAIDs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global NSAIDs Market Size Forecast by Type (2021-2026)
4.2.1 Global NSAIDs Sales Forecast by Type (2021-2026)
4.2.2 Global NSAIDs Revenue Forecast by Type (2021-2026)
4.2.3 NSAIDs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global NSAIDs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global NSAIDs Market Size by Application (2015-2020)
5.1.1 Global NSAIDs Sales by Application (2015-2020)
5.1.2 Global NSAIDs Revenue by Application (2015-2020)
5.1.3 NSAIDs Price by Application (2015-2020)
5.2 NSAIDs Market Size Forecast by Application (2021-2026)
5.2.1 Global NSAIDs Sales Forecast by Application (2021-2026)
5.2.2 Global NSAIDs Revenue Forecast by Application (2021-2026)
5.2.3 Global NSAIDs Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan NSAIDs Market Size YoY Growth 2015-2026
6.1.1 Japan NSAIDs Sales YoY Growth 2015-2026
6.1.2 Japan NSAIDs Revenue YoY Growth 2015-2026
6.1.3 Japan NSAIDs Market Share in Global Market 2015-2026
6.2 Japan NSAIDs Market Size by Players (International and Local Players)
6.2.1 Japan Top NSAIDs Players by Sales (2015-2020)
6.2.2 Japan Top NSAIDs Players by Revenue (2015-2020)
6.3 Japan NSAIDs Historic Market Review by Type (2015-2020)
6.3.1 Japan NSAIDs Sales Market Share by Type (2015-2020)
6.3.2 Japan NSAIDs Revenue Market Share by Type (2015-2020)
6.3.3 Japan NSAIDs Price by Type (2015-2020)
6.4 Japan NSAIDs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan NSAIDs Sales Forecast by Type (2021-2026)
6.4.2 Japan NSAIDs Revenue Forecast by Type (2021-2026)
6.4.3 Japan NSAIDs Price Forecast by Type (2021-2026)
6.5 Japan NSAIDs Historic Market Review by Application (2015-2020)
6.5.1 Japan NSAIDs Sales Market Share by Application (2015-2020)
6.5.2 Japan NSAIDs Revenue Market Share by Application (2015-2020)
6.5.3 Japan NSAIDs Price by Application (2015-2020)
6.6 Japan NSAIDs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan NSAIDs Sales Forecast by Application (2021-2026)
6.6.2 Japan NSAIDs Revenue Forecast by Application (2021-2026)
6.6.3 Japan NSAIDs Price Forecast by Application (2021-2026)
7 North America
7.1 North America NSAIDs Market Size YoY Growth 2015-2026
7.2 North America NSAIDs Market Facts & Figures by Country
7.2.1 North America NSAIDs Sales by Country (2015-2020)
7.2.2 North America NSAIDs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe NSAIDs Market Size YoY Growth 2015-2026
8.2 Europe NSAIDs Market Facts & Figures by Country
8.2.1 Europe NSAIDs Sales by Country
8.2.2 Europe NSAIDs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific NSAIDs Market Size YoY Growth 2015-2026
9.2 Asia Pacific NSAIDs Market Facts & Figures by Country
9.2.1 Asia Pacific NSAIDs Sales by Region (2015-2020)
9.2.2 Asia Pacific NSAIDs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America NSAIDs Market Size YoY Growth 2015-2026
10.2 Latin America NSAIDs Market Facts & Figures by Country
10.2.1 Latin America NSAIDs Sales by Country
10.2.2 Latin America NSAIDs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa NSAIDs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa NSAIDs Market Facts & Figures by Country
11.2.1 Middle East and Africa NSAIDs Sales by Country
11.2.2 Middle East and Africa NSAIDs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Description and Business Overview
12.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer NSAIDs Products Offered
12.1.5 Bayer Recent Development
12.2 Novacap
12.2.1 Novacap Corporation Information
12.2.2 Novacap Description and Business Overview
12.2.3 Novacap Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novacap NSAIDs Products Offered
12.2.5 Novacap Recent Development
12.3 Abbott
12.3.1 Abbott Corporation Information
12.3.2 Abbott Description and Business Overview
12.3.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Abbott NSAIDs Products Offered
12.3.5 Abbott Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Description and Business Overview
12.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer NSAIDs Products Offered
12.4.5 Pfizer Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Corporation Information
12.5.2 Johnson & Johnson Description and Business Overview
12.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Johnson & Johnson NSAIDs Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 Cigna
12.6.1 Cigna Corporation Information
12.6.2 Cigna Description and Business Overview
12.6.3 Cigna Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Cigna NSAIDs Products Offered
12.6.5 Cigna Recent Development
12.7 Geri-Care Pharmaceuticals
12.7.1 Geri-Care Pharmaceuticals Corporation Information
12.7.2 Geri-Care Pharmaceuticals Description and Business Overview
12.7.3 Geri-Care Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Geri-Care Pharmaceuticals NSAIDs Products Offered
12.7.5 Geri-Care Pharmaceuticals Recent Development
12.8 Perrigo Company
12.8.1 Perrigo Company Corporation Information
12.8.2 Perrigo Company Description and Business Overview
12.8.3 Perrigo Company Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Perrigo Company NSAIDs Products Offered
12.8.5 Perrigo Company Recent Development
12.9 Kopran
12.9.1 Kopran Corporation Information
12.9.2 Kopran Description and Business Overview
12.9.3 Kopran Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Kopran NSAIDs Products Offered
12.9.5 Kopran Recent Development
12.10 Merck Sharp & Dohme
12.10.1 Merck Sharp & Dohme Corporation Information
12.10.2 Merck Sharp & Dohme Description and Business Overview
12.10.3 Merck Sharp & Dohme Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Merck Sharp & Dohme NSAIDs Products Offered
12.10.5 Merck Sharp & Dohme Recent Development
12.11 Bayer
12.11.1 Bayer Corporation Information
12.11.2 Bayer Description and Business Overview
12.11.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bayer NSAIDs Products Offered
12.11.5 Bayer Recent Development
12.12 GlaxoSmithKline
12.12.1 GlaxoSmithKline Corporation Information
12.12.2 GlaxoSmithKline Description and Business Overview
12.12.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.12.4 GlaxoSmithKline Products Offered
12.12.5 GlaxoSmithKline Recent Development
12.13 Reddy Pharmaceuticals
12.13.1 Reddy Pharmaceuticals Corporation Information
12.13.2 Reddy Pharmaceuticals Description and Business Overview
12.13.3 Reddy Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Reddy Pharmaceuticals Products Offered
12.13.5 Reddy Pharmaceuticals Recent Development
12.14 Verywell
12.14.1 Verywell Corporation Information
12.14.2 Verywell Description and Business Overview
12.14.3 Verywell Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Verywell Products Offered
12.14.5 Verywell Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key NSAIDs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 NSAIDs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. NSAIDs Market Segments
Table 2. Ranking of Global Top NSAIDs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global NSAIDs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Aspirin
Table 5. Major Manufacturers of Ibuprofen
Table 6. Major Manufacturers of Naproxen
Table 7. Major Manufacturers of Nabumetone
Table 8. Major Manufacturers of Others
Table 9. Global NSAIDs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 10. Global NSAIDs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 11. Global NSAIDs Sales by Regions 2015-2020 (K MT)
Table 12. Global NSAIDs Sales Market Share by Regions (2015-2020)
Table 13. Global NSAIDs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global NSAIDs Sales Forecast by Region (2021-2026) (K MT)
Table 15. Global NSAIDs Sales by Manufacturers (2015-2020) (K MT)
Table 16. Global NSAIDs Sales Share by Manufacturers (2015-2020)
Table 17. Global NSAIDs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global NSAIDs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NSAIDs as of 2019)
Table 19. NSAIDs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. NSAIDs Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers NSAIDs Price (2015-2020) (USD/MT)
Table 22. NSAIDs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers NSAIDs Product Type
Table 24. Date of International Manufacturers Enter into NSAIDs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global NSAIDs Sales by Type (2015-2020) (K MT)
Table 27. Global NSAIDs Sales Share by Type (2015-2020)
Table 28. Global NSAIDs Revenue by Type (2015-2020) (US$ Million)
Table 29. Global NSAIDs Revenue Share by Type (2015-2020)
Table 30. NSAIDs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 31. Global NSAIDs Sales Share by Type (2021-2026)
Table 32. Global NSAIDs Sales by Application (2015-2020) (K MT)
Table 33. Global NSAIDs Sales Share by Application (2015-2020)
Table 34. Global NSAIDs Sales Share by Application (2021-2026)
Table 35. Global NSAIDs Sales Market Share Forecast by Application (2021-2026)
Table 36. Global NSAIDs Revenue by Application (2015-2020) (US$ Million)
Table 37. Global NSAIDs Revenue Market Share Forecast by Application (2021-2026)
Table 38. Japan NSAIDs Sales (K MT) of Key Companies (2015-2020)
Table 39. Japan NSAIDs Sales Share by Company (2015-2020)
Table 40. Japan NSAIDs Revenue (US$ Million) by Company (2015-2020)
Table 41. Japan NSAIDs Sales (K MT) by Type (2015-2020)
Table 42. Japan NSAIDs Sales Share by Type (2015-2020)
Table 43. Japan NSAIDs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. Japan NSAIDs Price (K MT) by Type (2015-2020)
Table 45. Japan NSAIDs Sales (K MT) by Type (2021-2026)
Table 46. Japan NSAIDs Sales Share by Type (2021-2026)
Table 47. Japan NSAIDs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. Japan NSAIDs Revenue Share by Type (2021-2026)
Table 49. Japan NSAIDs Price (K MT) by Type (2021-2026)
Table 50. Japan NSAIDs Sales (K MT) by Application (2015-2020)
Table 51. Japan NSAIDs Sales Share by Application (2015-2020)
Table 52. Japan NSAIDs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. Japan NSAIDs Sales (K MT) by Application (2021-2026)
Table 54. Japan NSAIDs Sales Share by Application (2021-2026)
Table 55. Japan NSAIDs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. Japan NSAIDs Revenue Share by Application (2021-2026)
Table 57. North America NSAIDs Sales by Country (2015-2020) (K MT)
Table 58. North America NSAIDs Sales Market Share by Country (2015-2020)
Table 59. North America NSAIDs Revenue by Country (2015-2020) (US$ Million)
Table 60. North America NSAIDs Revenue Market Share by Country (2015-2020)
Table 61. Europe NSAIDs Sales by Country (2015-2020) (K MT)
Table 62. Europe NSAIDs Sales Market Share by Country (2015-2020)
Table 63. Europe NSAIDs Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe NSAIDs Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific NSAIDs Sales by Region (2015-2020) (K MT)
Table 66. Asia Pacific NSAIDs Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific NSAIDs Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific NSAIDs Revenue Market Share by Region (2015-2020)
Table 69. Latin America NSAIDs Sales by Country (2015-2020) (K MT)
Table 70. Latin America NSAIDs Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa NSAIDs Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America NSAIDs Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa NSAIDs Sales by Country (2015-2020) (K MT)
Table 74. Middle East and Africa NSAIDs Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa NSAIDs Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa NSAIDs Revenue Market Share by Country (2015-2020)
Table 77. Bayer Corporation Information
Table 78. Bayer Description and Business Overview
Table 79. Bayer NSAIDs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Bayer NSAIDs Product
Table 81. Bayer Recent Development
Table 82. Novacap Corporation Information
Table 83. Novacap Description and Business Overview
Table 84. Novacap NSAIDs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Novacap Product
Table 86. Novacap Recent Development
Table 87. Abbott Corporation Information
Table 88. Abbott Description and Business Overview
Table 89. Abbott NSAIDs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Abbott Product
Table 91. Abbott Recent Development
Table 92. Pfizer Corporation Information
Table 93. Pfizer Description and Business Overview
Table 94. Pfizer NSAIDs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Pfizer Product
Table 96. Pfizer Recent Development
Table 97. Johnson & Johnson Corporation Information
Table 98. Johnson & Johnson Description and Business Overview
Table 99. Johnson & Johnson NSAIDs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Johnson & Johnson Product
Table 101. Johnson & Johnson Recent Development
Table 102. Cigna Corporation Information
Table 103. Cigna Description and Business Overview
Table 104. Cigna NSAIDs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Cigna Product
Table 106. Cigna Recent Development
Table 107. Geri-Care Pharmaceuticals Corporation Information
Table 108. Geri-Care Pharmaceuticals Description and Business Overview
Table 109. Geri-Care Pharmaceuticals NSAIDs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Geri-Care Pharmaceuticals Product
Table 111. Geri-Care Pharmaceuticals Recent Development
Table 112. Perrigo Company Corporation Information
Table 113. Perrigo Company Description and Business Overview
Table 114. Perrigo Company NSAIDs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Perrigo Company Product
Table 116. Perrigo Company Recent Development
Table 117. Kopran Corporation Information
Table 118. Kopran Description and Business Overview
Table 119. Kopran NSAIDs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Kopran Product
Table 121. Kopran Recent Development
Table 122. Merck Sharp & Dohme Corporation Information
Table 123. Merck Sharp & Dohme Description and Business Overview
Table 124. Merck Sharp & Dohme NSAIDs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. Merck Sharp & Dohme Product
Table 126. Merck Sharp & Dohme Recent Development
Table 127. Sun Pharmaceutical Industries Corporation Information
Table 128. Sun Pharmaceutical Industries Description and Business Overview
Table 129. Sun Pharmaceutical Industries NSAIDs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 130. Sun Pharmaceutical Industries Product
Table 131. Sun Pharmaceutical Industries Recent Development
Table 132. GlaxoSmithKline Corporation Information
Table 133. GlaxoSmithKline Description and Business Overview
Table 134. GlaxoSmithKline NSAIDs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 135. GlaxoSmithKline Product
Table 136. GlaxoSmithKline Recent Development
Table 137. Reddy Pharmaceuticals Corporation Information
Table 138. Reddy Pharmaceuticals Description and Business Overview
Table 139. Reddy Pharmaceuticals NSAIDs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 140. Reddy Pharmaceuticals Product
Table 141. Reddy Pharmaceuticals Recent Development
Table 142. Verywell Corporation Information
Table 143. Verywell Description and Business Overview
Table 144. Verywell NSAIDs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 145. Verywell Product
Table 146. Verywell Recent Development
Table 147. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 148. Key Challenges
Table 149. Market Risks
Table 150. Main Points Interviewed from Key NSAIDs Players
Table 151. NSAIDs Customers List
Table 152. NSAIDs Distributors List
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. NSAIDs Product Picture
Figure 2. Global NSAIDs Sales Market Share by Type in 2020 & 2026
Figure 3. Aspirin Product Picture
Figure 4. Ibuprofen Product Picture
Figure 5. Naproxen Product Picture
Figure 6. Nabumetone Product Picture
Figure 7. Others Product Picture
Figure 8. Global NSAIDs Sales Market Share by Application in 2020 & 2026
Figure 9. Back Pain Treatment
Figure 10. Osteoarthritis Treatment
Figure 11. Other Disease Treatment
Figure 12. NSAIDs Report Years Considered
Figure 13. Global NSAIDs Market Size 2015-2026 (US$ Million)
Figure 14. Global NSAIDs Sales 2015-2026 (K MT)
Figure 15. Global NSAIDs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global NSAIDs Sales Market Share by Region (2015-2020)
Figure 17. Global NSAIDs Sales Market Share by Region in 2019
Figure 18. Global NSAIDs Revenue Market Share by Region (2015-2020)
Figure 19. Global NSAIDs Revenue Market Share by Region in 2019
Figure 20. Global NSAIDs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by NSAIDs Revenue in 2019
Figure 22. NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global NSAIDs Sales Market Share by Type (2015-2020)
Figure 24. Global NSAIDs Sales Market Share by Type in 2019
Figure 25. Global NSAIDs Revenue Market Share by Type (2015-2020)
Figure 26. Global NSAIDs Revenue Market Share by Type in 2019
Figure 27. Global NSAIDs Market Share by Price Range (2015-2020)
Figure 28. Global NSAIDs Sales Market Share by Application (2015-2020)
Figure 29. Global NSAIDs Sales Market Share by Application in 2019
Figure 30. Global NSAIDs Revenue Market Share by Application (2015-2020)
Figure 31. Global NSAIDs Revenue Market Share by Application in 2019
Figure 32. Japan NSAIDs Sales Growth Rate 2015-2026 (K MT)
Figure 33. Japan NSAIDs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 34. Japan NSAIDs Market Share in Global Market 2015-2026
Figure 35. Japan 5 and 10 Largest NSAIDs Players Market Share by Revenue in NSAIDs in 2019
Figure 36. Japan NSAIDs Revenue Share by Type (2015-2020)
Figure 37. Japan NSAIDs Revenue Growth Rate by Type in 2015 & 2019
Figure 38. Japan NSAIDs Revenue Share by Application (2015-2020)
Figure 39. Japan NSAIDs Revenue Growth Rate by Application in 2015 & 2019
Figure 40. North America NSAIDs Sales Growth Rate 2015-2020 (K MT)
Figure 41. North America NSAIDs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. North America NSAIDs Sales Market Share by Country in 2019
Figure 43. North America NSAIDs Revenue Market Share by Country in 2019
Figure 44. U.S. NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 45. U.S. NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Canada NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 47. Canada NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Europe NSAIDs Sales Growth Rate 2015-2020 (K MT)
Figure 49. Europe NSAIDs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 50. Europe NSAIDs Sales Market Share by Country in 2019
Figure 51. Europe NSAIDs Revenue Market Share by Country in 2019
Figure 52. Germany NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Germany NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. France NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 55. France NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. U.K. NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 57. U.K. NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Italy NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 59. Italy NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Russia NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 61. Russia NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Asia Pacific NSAIDs Sales Growth Rate 2015-2020 (K MT)
Figure 63. Asia Pacific NSAIDs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific NSAIDs Sales Market Share by Region in 2019
Figure 65. Asia Pacific NSAIDs Revenue Market Share by Region in 2019
Figure 66. China NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 67. China NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 69. Japan NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 71. South Korea NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 73. India NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Australia NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Taiwan NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Indonesia NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Thailand NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 83. Malaysia NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 85. Philippines NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 87. Vietnam NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Latin America NSAIDs Sales Growth Rate 2015-2020 (K MT)
Figure 89. Latin America NSAIDs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America NSAIDs Sales Market Share by Country in 2019
Figure 91. Latin America NSAIDs Revenue Market Share by Country in 2019
Figure 92. Mexico NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 93. Mexico NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 95. Brazil NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 97. Argentina NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Middle East and Africa NSAIDs Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa NSAIDs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa NSAIDs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa NSAIDs Revenue Market Share by Country in 2019
Figure 102. Turkey NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E NSAIDs Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E NSAIDs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Porter's Five Forces Analysis
Figure 109. NSAIDs Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs